May 28
|
Eli Lilly to Expand Pain Pipeline With $1B SiteOne Buyout Offer
|
May 28
|
Eli Lilly vs. AstraZeneca: Which Pharma Powerhouse is the Better Buy?
|
May 27
|
Jim Cramer Notes Eli Lilly (LLY) Stock is at a “Decent Level to Start a Position”
|
May 27
|
Sector Update: Health Care Stocks Advance Late Afternoon
|
May 27
|
Eli Lilly Targets Pain Management Opportunity with SiteOne Therapeutics Acquisition
|
May 27
|
Eli Lilly Strikes up to $1 Billion Deal for SiteOne Therapeutics in Bid to Grow Pain Drug Pipeline
|
May 27
|
Eli Lilly to expand pain pipeline with $1bn SiteOne buyout
|
May 27
|
Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics
|
May 27
|
What’s the Price Outlook for Weight-Loss Drugs?
|
May 27
|
Lilly to expand its pain pipeline with acquisition of SiteOne Therapeutics
|
May 27
|
Lilly to buy pain drug developer SiteOne, challenging Vertex
|
May 27
|
Here's How the Pharmaceutical Import Tariffs Could Affect Eli Lilly
|
May 27
|
Prediction: These 2 Stocks Will Beat the Market in the Next Decade
|
May 26
|
Should Everyone Be Taking Ozempic? Doctors Say More People Could Benefit
|
May 24
|
Why Hims & Hers Health Stock (HIMS) Is Too Hot to Handle
|
May 23
|
3 Stocks Targeting Weight Loss Market With Cannabinoid-Based Therapies
|
May 23
|
The Zacks Analyst Blog Highlights Eli Lilly, GE Aerospace and Amgen
|
May 23
|
2 Growth Stocks to Own for Decades and 1 to Steer Clear Of
|
May 11
|
President Trump Just Announced Terrible News for Eli Lilly Investors
|
May 11
|
Prediction: These 2 Stocks Will Join the Trillion-Dollar Club by 2030
|